Clinical Trials Browser

Phase 3 × Completed × pasireotide × Clear all

NCT02354508 2019-12-10

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Phase 3 Completed

123 enrolled 27 charts

Acromegaly, Gigantism, Growth Disorders, Pituitary Neoplasms

NCT01137682 2018-04-05

PAOLA

Phase 3 Completed

198 enrolled 17 charts

Acromegaly, Pituitary Neoplasms

NCT00994110 2016-02-01

Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess

Phase 3 Completed

439 enrolled 7 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00690430 2013-07-30

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

Phase 3 Completed

186 enrolled 11 charts

Carcinoid Tumor